TABLE 1.

Detailed clinical information of six patients.

Sample No.	Age	Histological	Ki-67 (%)	T stage	N stage	NAC regimen	DFS (month)	Metastatic sites
1	35	Right breast nonspecific type of invasive cancer grade III flap intravascular cancer thromboembolus (MP2)	40	T2	N3	TEC∗2-NP∗2	5	Brain
2	46	Left breast invasive carcinoma (MP3)	40	T4d	N3	TAC∗3	5	Chest wall
3	60	Right breast nonspecific invasive ductal carcinoma (MP2)	80	T4a	N2	TE∗2—NP∗5	7	Liver
4	44	Right breast nonspecific invasive ductal carcinoma grade III(MP2)	80	T2	N1	TE∗6	23	Liver
5	38	Left breast nonspecific type of invasive cancer grade III	90	T3	Nx	TEC∗3	13	Lung
6	52	Right breast nonspecific type of invasive cancer grade II(MP2)	50	T2	N1	EC-T∗8	14	Multiple metastases (lymph nodes, two lungs, and bone)

TEC, docetaxel, epirubici, and cyclophosphamide; NP, vinorelbine and cisplatin/carboplatin; TAC, docetaxel, doxorubicin, and cyclophosphamide; TE, docetaxel and epirubici; EC-T, epirubici/cyclophosphamide followed by paclitaxel.